OtherHormones Therapy
Anastrozole · Aromatase inhibitor
Anastrozole is classed as a aromatase inhibitor and is supplied as tablets. Its standard indications include hormone receptor-positive breast cancer in postmenopausal women, and it is offered for pharmaceutical supply and export.
Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.
01Specification
02Related